Comments

Bright Minds Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Bright Minds Biosciences (DRUG) operate in?

Bright Minds Biosciences is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

DRUGNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$35.99

At close: Mar 5, 4:19 PM EDT

$35.29

-0.70-1.94%

After Hours: 4:19 PM EDT

Bright Minds Biosciences (DRUG) Forecast

News Earnings Bright Minds Biosciences (DRUG) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Bright Minds Biosciences Stock Price, Quotes and Forecasts | NASDAQ:DRUG | Benzinga

Explore Bright Minds Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DRUG.

Open	-
Close	-
Volume / Avg.	0 / 80.74K
Day Range	- - -
52 Wk Range	0.93 - 79.02
Market Cap	$248.58M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	2.64%
Days to Cover	1.9

Recent News

Biotechs on the Brink: 2 Stocks With Huge Potential

Investors know the biotech industry is a waiting game—smaller companies in this space often work to secure the funding to keep their doors open during a pre-revenue period while they develop drug treatments and

MarketBeat

This Prudential Financial Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?

A look at the most-searched tickers on Benzinga Pro for the month of October. Donald Trump and biotech stocks joined the top 10.

Chris Katje

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 80.74K
Day Range	- - -
52 Wk Range	0.93 - 79.02
Market Cap	$248.58M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	2.64%
Days to Cover	1.9

About

Sector

Healthcare

Industry

N/A

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsych...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Bright Minds Biosciences (DRUG) stock?

You can purchase shares of Bright Minds Biosciences (NASDAQ:DRUG) through any online brokerage.

View our list of the best stock brokerages

Who are Bright Minds Biosciences (DRUG) competitors?

There are no as such competitors for Bright Minds Biosciences.

What is the forecast, or price target, for Bright Minds Biosciences (DRUG) stock?

Bright Minds Biosciences has a consensus price target of $84.33.

What is the current price for Bright Minds Biosciences (DRUG)?

The stock price for Bright Minds Biosciences (NASDAQ: DRUG) is $35.29 last updated March 5, 2025 at 4:19 PM EST.

Does Bright Minds Biosciences (DRUG) pay a dividend?

There are no upcoming dividends for Bright Minds Biosciences.

When is Bright Minds Biosciences (NASDAQ:DRUG) reporting earnings?

Bright Minds Biosciences’s Q2 earnings are confirmed for Friday, May 16, 2025.

Is Bright Minds Biosciences (DRUG) going to split?

There is no upcoming split for Bright Minds Biosciences.

What sector and industry does Bright Minds Biosciences (DRUG) operate in?

Bright Minds Biosciences is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.